To test the hypothesis that the levels of bone remodeling mediators (RANKL, OPG, sclerostin, DKK-1 serum levels, and bone metabolism markers) may be altered in PWS subjects. The gene discussed is TNFSF11; the disease is Prader-Willi syndrome.